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Abstract
Liver Sinusoidal Endothelial Cells (LSEC) differ, both structurally and functionally, from
endothelial cells (EC) lining blood vessels of other tissues. For example, in contrast to other EC,
LSEC posses fenestrations, have low detectable levels of PECAM-1 expression, and in rat tissue,
they distinctively express a cell surface marker recognized by the SE-1 antibody. These unique
phenotypic characteristics seen in hepatic tissue are lost over time upon culture in vitro; therefore,
this study sought to systematically examine the effects of microenvironmental stimuli, namely,
extracellular matrix (ECM) and neighboring cells, on the LSEC phenotype in vitro. In probing the
role of the underlying extracellular matrix, we identified collagen I and collagen III as well as
mixtures of collagen I/collagen IV/fibronectin as having a positive effect on LSEC survival.
Furthermore, using a stable hepatocellular model (hepatocyte-fibroblast) we were able to prolong
the expression of both SE-1 and phenotypic functions of LSEC such as Factor VIII activity in co-
cultured LSECs through the production of short-range paracrine signals. In the course of these
experiments, we identified the antigen recognized by SE-1 as CD32b. Collectively, this study has
identified several microenvironmental regulators of liver sinusoidal endothelial cells that prolong
their phenotypic functions for up to 2 weeks in culture, enabling the development of better in vitro
models of liver physiology and disease.
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Introduction
Liver sinusoidal endothelial cells (LSEC) are specialized endothelial cells that play
important roles in liver physiology and disease (1). LSEC have several features that
distinguish them from other endothelial cells (EC). Morphologically, they are characterized
by the presence of open fenestrae arranged in sieve plates, and the lack of an organized
basement membrane (2). Functionally, LSEC also can act as scavengers, eliminating soluble
waste macromolecules from portal venous blood or immune complexes (3); are critical for
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inducing CD8+T cell tolerance (4); and synthesize and release Factor VIII, a critical co-
factor in the intrinsic coagulation pathway (5,6). Thus, it is evident that a distinct endothelial
phenotype is required for the specialized functions of the liver in vivo. Upon isolation from
the hepatic microarchitecture, LSEC lose many of their phenotypic functions. We and others
have previously demonstrated that the modulation of the hepatocellular phenotypes in vitro
can lead to the development of robust in vitro models of some aspects of liver biology (7,8)
(29).. Here, we investigate the role of the cellular microenvironment on the LSECs
phenotype in vitro with the goal of elucidating fundamental aspects of LSEC biology as well
as improving the fidelity of in vitro models of liver tissue.
One of the major challenges in LSEC biology has been the lack of a gold standard
biochemical marker for the normal, differentiated LSEC phenotype. The morphological gold
standard is the visualization of fenestrations by scanning electron microscopy, a method
fraught with technical limitations. The closest biomarker for LSEC phenotype is the antigen
recognized by the SE-1 antibody (9). This antibody, unlike those that recognize the
ubiquitous endothelial marker CD31, is specific to LSEC in rat tissue, and expression of the
SE-1 antigen has been show to positively correlate with the presence of fenestrations..
However, the unknown identity of this antigen has made it difficult to translate findings in
the rat liver to other species such as mouse and human or to perturb it with molecular tools
such as RNA interference. Over the course of our studies, we sought to identify the antigen
for SE-1 to address these challenges and aid in the mapping of our findings to a medical
framework.
When cultured alone after isolation, rat LSEC lose expression of SE-1, increase expression
of CD31, and undergo apoptosis after 2 days (10,11). Studies on the role of the
microenvironment have shown that perturbations of the underlying matrix can prolong the
maintenance of fenestrations (12). Co-cultivation with primary hepatocytes can also prolong
the loss of phenotype for several days as measured by continued expression of the SE-1
antigen (13), suppression of CD31 expression (10), and stimulation of proliferation (14).
This effect is thought to be due to paracrine signals such as VEGF but limited in duration, in
part, due to the concomitant loss of hepatocyte phenotype over several days in culture. In the
present study, we exploit two microtechnology platforms previously developed in our group
to systematically examine the effect of cell-matrix and cell-cell interactions on LSEC
survival and phenotype (15,16). These platforms allow the investigation of LSEC responses
to individual matrix species collagen I, collagen III, collagen IV, fibronectin, and laminin
and their combinations, as well as enable analysis of the relative impact of contact versus
diffusible paracrine signals in co-culture with hepatocytes. In the course of these studies, we
also identify the antigen recognized by the SE-1 antibody and map our findings to both
mouse and human LSEC.
Materials and Methods
Isolation and culture of Hepatocytes, Sinusoidal Endothelial cells and fibroblasts
See supplemental information.
Co-culture of LSEC with neighboring cells
Cellular co-cultures were performed using a recently developed micromechanical
reconfigurable culture method to enable tracking of individual cell types, separation into
pure populations for analysis, and deconvolution of contact-mediated versus soluble signals
(16). See supplemental information for details.
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Protein Purification, and Identification by Mass Spectrometry
Isolated LSEC were cultured for one day, and lysed in 1 ml of RIPA buffer (Upstate
Biotechnology, Walthem, MA) with protease inhibitors cocktail (Roche, Idianapolis, IN).
MAb against SE-1 was covalently coupled to CNBr-activated Sepharose 4B (Amersham,
Uppsala, Sweden) and used to affinity-purity the unknown cell surface antigen from LSEC
lysates as previously described (17). The isolated protein was identified by peptide mass
fingerprinting using LTQ linear ion-trap mass spectrometer (ThermoFisher, San Jose, CA)
(supplemental methods).
Rat CD32b Cloning and Transfection
CD32b cDNA was synthesized (GENEART, Regensburg, Germany) and cloned using the
pcDNA3.1 vector. HEK cells were transfected with the rat CD32b or an empty vector using
Lipofectamine. Analysis was performed by FACS and Western Blot.
Factor VIII assay
Factor VIII activity was assayed as previously described using the Coatest C/4 kit
(Diapharm, Franklin, OH) (18).
ECM Array
ECM arrays containing combinatorial mixtures of ECM molecules were fabricated as
previously described (15).
Statistical Analysis
Experiments were repeated 3 times with duplicate or triplicate samples for each condition.
For functional assays, one representative outcome is presented. All data are expressed as
mean ± standard deviation. Statistical significance was determined using the Student’s t test
(Microsoft Excel).
Uptake of acetylated low-density lipoprotein
Cultured cells were incubated with a medium containing 5µg/ml of acetylated Low-Density
Lipoprotein (LDL)-Alexa 488 conjugated (Molecular Probes, Eugene, OR) for 4h at 37°C
and examined by fluorescence microscopy.
Results
Expression of endothelial markers in hepatic tissue and in cultured LSEC
To characterize the phenotype of EC in intact hepatic tissue, and after their isolation and
culture, we used several previously described markers for EC present in distinct hepatic
vascular beds. These included SE-1, PECAM-1 and RECA. As seen in Figure 1A (top
panel), immunohistochemistry with the endothelial marker SE-1 on rat liver sections
demonstrated a strong staining of the sinusoidal endothelial cells. No reactivity was
observed in central and the portal tract endothelium. In contrast, PECAM-1 was highly
expressed in central and the portal tract endothelium and very low expression was detected
in the LSEC. The RECA antibody stained the EC of both the sinusoids and large vessels.
Next, we assessed the expression of the endothelial markers SE-1, PECAM-1 and RECA, in
cultured LSEC at 1 and 3 days after isolation. At day 1, the in vitro expression of SE-1,
PECAM-1 and RECA, correlate with the in vivo expression of these markers. Nevertheless,
we documented a strong decrease in the expression of SE-1 and an increase in the
expression of PECAM-1 at day 3 post-isolation. The expression of RECA did not display
significant changes (Figure 1A middle and lower panels and Figure 1B). Scanning electron
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microscopy (SEM) verified that the cell membrane of isolated LSEC at day 1 contained
sieve plates with grouped fenestrae (Figure 1A and supplemental Figure 1).
Identification of the antigen recognized by the SE-1 antibody
To begin linking the expression of the LSEC marker SE-1 to cellular function, we performed
affinity purification of the protein recognized by the SE-1 antibody from LSEC lysates,
followed by mass spectrometry analysis These experiments revealed the protein to be
CD32b (Figure 2A). To confirm the identity of the recognized protein, LSEC lysates were
immunoprecipitated with a SE-1 antibody and the immunoprecipitated material was detected
by western blot using two different anti-CD32 antibodies. In both cases the SE-1 antibody
and the anti-CD32 recognized the same antigen (Figure 2B). Furthermore, the CD32b cDNA
was transiently transfected in HEK cells and probed with the antibody against SE-1. In these
experiments, CD32b expressed in HEK cells was recognized by mAb SE-1 using both flow
cytometry and western blot analysis (Figure 2C). Inmunohistochemical analyses showed that
SE-1 and the polyclonal CD32b antibody staining co-localized in rat liver sections (Figure
2D). We also demonstrated LSEC as the main source of CD32b (supplemental Figure 2).
Taken together, these data demonstrate that the SE-1 antibody recognizes the cell surface
receptor CD32b.
The identification of the antigen recognized by SE-1, the CD32b molecule, allowed us to
extend our studies to mouse and human LSEC since the SE-1 antibody does not cross-react
with these species. We assessed the expression of CD32b in human and mouse LSEC by
western blot. In both cases, we showed a downregulation of CD32b over time (Figure 2, E
and F), demonstrating that this pattern is conserved across several species. Interestingly, in
vivo, expression of CD32b in mouse liver also correlated with patterns of SE-1 staining in
rat liver (Supplemental Figure 3C).
Effect of the ECM on the survival of Liver Sinusoidal Endothelial Cells in Culture
To assess the effects of different components of extracellular matrix on the fate of primary
rat LSEC we patterned cells atop combinatorial matrix mixtures of interstitial matrix
molecules (fibronectin, collagen I, collagen III) and basement membrane components
(laminin, collagen IV), using a microarray platform we have previously described (15). At
day 1 after seeding, LSEC expressed high and similar levels of SE-1(CD32b) and low levels
of PECAM-1 across all conditions. All islands showed similar number of endothelial cells
and absence of apoptotic nuclei on day 1. The presence of attached EC on each island on
day 2 and 3 as detected by microscopy was used to score survival over time. A
representative part of the array is shown in figure 3A. In contrast to the first day after
seeding, notable differences in the number of surviving cells and the percentage of apoptotic
nuclei per island emerged over the next 48 hours. The differences in survival and apoptosis
were dependent on the initial underlying matrix composition (representative images are
shown in figure 3B). Islands containing collagen I or III exhibited the lowest percentage of
apoptotic nuclei per island and the highest number of cells per island. In contrast, fibronectin
and laminin negatively affected the survival of LSEC, correlating with the highest
percentage of apoptotic nuclei per island and the lowest number of cells per island. Factorial
analysis revealed that collagen I and collagen III have significant positive effects on cell
survival, and laminin has a strong negative effect. We also identified the positive effect of
the mixture of collagen I/collagen IV/fibronectin in reducing apoptotic nuclei, and
increasing cell number. Interestingly, collagen IV alone did not modulate cell survival;
however, in the context of collagen I and III, it had positive effects (Figure 3, C and D).
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Role of supportive cells in maintaining LSEC phenotype
Our laboratory and others have previously shown that co-culture of hepatocytes with 3T3
fibroblasts can rescue the loss of the hepatocellular phenotype in culture (8), and that both
cell contact and short-range paracrine signals were necessary for rescue (16). Here, we used
a similar approach to assess the role of supportive cells in maintaining the LSEC phenotype
in culture. Co-cultures were performed using a reconfigurable cell culture substrate (16).
The system can be configured in ‘contact’ mode, where contact-mediated signaling can
occur between the two populations, or in ‘gap’ mode, where the populations are separated
by an 80-µm gap and can only communicate by diffusible soluble signals (Figure 4A).
Using this platform, LSEC were cultured together with 3 different combinations of
neighboring cells including; a) hepatocytes b) hepatocytes mixed with 3T3 fibroblasts as a
‘stable’ liver tissue model and c) 3T3 fibroblasts (Figure 4B). In each case, co-cultures were
performed in both gap (80 µm separation) and in contact configuration.
Inmunocytochemical and western blot analysis showed that the expression of SE-1(CD32b)
was optimally maintained in cultures combining LSEC with hepatocytes and 3T3 fibroblasts
(Figure 4, C and E). We also measured Factor VIII activity as a biochemical marker of
LSEC phenotype and Ac-LDL uptake as a measure of the endocytic capability of LSEC. As
with SE-1, co-cultures of LSEC with hepatocytes and fibroblasts maintained the highest
uptake of Ac-LDL (Figure 4G) and produced the highest levels of Factor VIII. (Figure 4F).
No significant Factor VIII activity was detected in hepatocyte or hepatocyte/fibroblast co-
cultures, confirming that Factor VIII is produced solely by LSEC (data not shown). As
expected, albumin secretion- a measure of hepatocellular function-was highest in the
cultures containing hepatocyte/fibroblast co-cultures (Figure 4D). Thus, ’tri-cultures’ of
LSEC with hepatocyte and fibroblasts atop collagen I provided the best cellular
microenvironment of the conditions tested for retention of the LSEC phenotype. We also
measured LSEC proliferation, while hepatocytes and hepatocytes/fibroblast co-cultures did
enhance LSEC proliferation, however, the increase in labeling index of approximately 20%
of nuclei was unlikely to be sufficient to account for the 2- to 3-fold increase in phenotypic
functions. In contrast, we did not observe any effect of fibroblasts alone on LSEC
(supplemental Figure 4).
We sought to determine whether contact between the cell populations was required for
rescue of the LSEC phenotype. Thus, we compared LSECs cultured in gap and contact
modes. Western blots of SE-1 (CD32b) demonstrated that the degree of rescue obtained
from short-range soluble signals in ‘gap’ mode was equivalent to that obtained in contact
mode (Figure 4H). Thus, our findings indicate that hepatocyte/fibroblast co-culture
stabilizes the LSEC phenotype through diffusible factors. In order to identify these soluble
factors. First, we examined the expression levels of several cytokines in the conditioned
media of the different culture combinations by using a rat cytokine microarray system
containing antibodies against 19 cytokines and other proteins. Using this approach, we did
not detect any significant changes between this cytokine panel in the well-mixed media after
24 h of conditioning; however, differences that occur over shorter time scales would not be
detectable in this platform (Supplemental Figure 5). Second we performed transcriptome
measurements in order to identify soluble factors secreted by hepatocytes upon co-culture
with fibroblast. Data from these experiments identified seventeen distinct genes upregulated
in hepatocytes and with predicted effects on the endothelium (supplemental Table 1). Thus,
in order to assess whether labile diffusible factors could propagate signals between cell
populations over longer distance than 80 microns, we performed transwell experiments
where LSEC shared their media with hepatocyte/fibroblast co-cultures but were separated by
1 mm. Neither the transwell nor conditioned media models were able to rescue the
expression of SE-1(CD32b) as was seen in the short-range ‘gap’ and contact co-cultures
(Figure 4I, and data not shown).
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Finally, we evaluated the longevity of SE-1 expression under different conditions. At day
14, SE-1 (CD32b) expression was only detectable in the ‘tri-culture’ configuration Notably,
over this second week of culture, expression of SE-1 was increased in contact cultures as
compared to 80 micron gap culture. Furthermore, in the contact mode at day 14 we observed
a migration of the LSEC towards the hepatocyte/fibroblast domain, and these cells express
the highest levels of SE-1. These data suggest that reciprocal signaling or contact-mediated
signals may play a role over the second week of culture (Figure 4J).
Discussion
The current study was designed to examine the effect of distinct microenviromental stimuli,
in particular extracellular matrix components and paracrine effects of supportive cell types,
on the LSEC phenotype. Using two novel platforms, we demonstrated that specific matrix
molecules and short-range soluble signals emanating from a relatively stable hepatocellular
model (hepatocyte/fibroblast co-cultures) are able to prolong survival and the expression of
LSEC phenotypic markers (SE-1 expression and Factor VIII activity) for up to 2 weeks.
Notably, the antigen recognized by the antibody SE-1, was identified as CD32b. This
particular finding will allow us to better understand the putative role of CD32b (SE-1) on
liver sinusoidal endothelial cells, extend this type of study to other species (e.g., mouse and
human), and perturb this antigen with molecular tools such as RNA interference.
In our model, the expression of endothelial CD32b was maintained for up to 14 days in an
optimal configuration involving co-cultivation of LSEC with both hepatocytes and
fibroblasts. CD32b is a low-affinity Fcγ receptor constitutively expressed by human adult
liver sinusoidal endothelial cells that has the same expression pattern as that previously
described for SE-1 in rats, where only the sinusoidal and not the endothelial cells of the
large vessels express the antigen (19). Here, we demonstrated that during the process of
LSEC differentiation in culture, there is a loss of CD32b expression in rat, mouse and
human LSEC, which shares the same dynamics with the loss of the ‘gold standard’
phenotypic marker, cytoplasmic fenestrations (20,21). CD32b2 plays a major role in the
endocytosis of immune complexes in the rat and has been found to be dysregulated in
disease, potentially linking the LSEC phenotype with the accumulation of immune
complexes observed in some human liver diseases (19,22).
Previous studies have shown that hepatocytes co-cultured with fibroblasts can retain a
differentiated hepatocyte phenotype over several weeks in culture (23,24). In this study, we
observed that the co-cultivation of LSEC with hepatocyte/fibroblast co-cultures are better
able to preserve the hepatocyte phenotype (as determined by the expression of SE-1, up-take
of Ac-LDL and Factor VIII activity) than hepatocyte/LSEC cultures under the conditions
tested, demonstrating that the ‘tri-culture’ model has the potential to promote the
stabilization of both EC and hepatocytes for up to two weeks. Recent evidence points to the
importance of the LSEC as a source of Factor VIII, a critical co-factor in the intrinsic
coagulation pathway (6). Our findings on the effect of neighboring cells on LSEC are
consistent with observations in the literature. For example, a small population of SE-1
positive cells was observed over 13 days in a 3D perfused co-culture of hepatocytes and
LSECs (13) where the hepatocytes in the 3D perfused environment are more phenotypically
stable than in monolayer culture (25). In short-term experiments (up to day 4) hepatocytes
(that are concurrently losing their phenotype) have been shown to prevent CD31 expression
and stimulate proliferation in EC (10,14). Thus, it is reasonable to expect that a monolayer
tissue model that combines a relatively stable hepatocyte phenotype (hepatocytes/
fibroblasts) with LSECs would support the LSEC phenotype over a relatively long time-
scale. Previous studies have shown that LSECs can positively impact hepatocyte function in
culture at early time points (24 hours) (26). In comparison, hepatocyte functions in the 3T3
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co-culture model reported here stabilize over approximately 5–7 days. Thus, the generation
of 'tri-cultures' to stabilize LSEC function may also have beneficial effects on hepatocyte
function early in culture.
Our studies indicate that diffusible factors emanating over short distances, L, (80 micron < L
< 1 mm), were responsible for the rescue of the endothelial phenotype over the first week in
culture. In vivo, it is feasible that hepatocytes and endothelial cells communicate via
diffusible signals over short-length scales such as those in the Space of Disse. In an attempt
to identify diffusible factors that may play a role in this process, we conducted a
comparative analysis of 19 cytokines in the media to determine whether a single factor could
be identified to explain these findings; however, no significant differences were identified
between supportive (hepatocyte/fibroblast) and non-supportive (fibroblasts or hepatocytes
alone) cultures. We also performed a gene expression profiling study comparing hepatocytes
and hepatocytes in co-culture with fibroblasts aiming to reveal potential soluble factors that
could be contribute to the maintenance of the LSEC phenotype. The candidates revealed by
these experiments include pleiotrophin, IGF-I, and angiotensin which potential action in this
context correlate with the previously published data (see table 1, supplementary material)
We also examined the independent role of extracellular matrix coatings on LSEC phenotype.
In liver fibrosis, there is a shift in the type of ECM in the space of Disse from the normal
low density basement membrane-like matrix (collagen IV, V and laminin) to interstitial type
matrix containing fibril-forming collagen (mainly collagen I and III) (27). In our array, these
different matrix and their mixtures were included to simulate the in vivo microenvironment
and to capture the transformation of matrix composition observed in liver fibrosis. Our
experiments identified the interstitial matrix collagen I and III and mixtures of collagen I/
collagen IV/fibronectin having a positive effect on LSEC survival. These findings are
consistent with prior reports that combinations of extracellular matrix can modulate LSEC
fenestrations (12); however, the positive role of fibrillar matrix on LSECs in culture was not
expected. Alteration of integrin expression or signaling could explain these findings, and in
vivo it has been shown that LSEC integrin expression is altered during the process of
capillarization in liver cirrhosis (28).
Taken together these studies have revealed several factors that are critical for the
maintenance of the functional phenotype of LSEC in culture. This experimental framework
should contribute to our understanding of the complex circuitry necessary to maintain
cellular function in vivo and in vitro and may provide an in vitro model that captures the
phenotype of multiple hepatic cell populations over many days in culture. In the future,
incorporation of additional non-parenchymal cells such as cholangiocytes and stellate cells
will allow even higher fidelity liver models to be assembled and investigated.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Abbreviations
LSEC Liver sinusoidal endothelial cell
PECAM Platelet endothelial cell adhesion molecule
EC endothelial cell
RECA Rat endothelial cell antigen
Hep Hepatocyte
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Fib Fibroblast
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Figure 1. Characterization of LSEC In Vivo and In Vitro
(A) Liver sections of normal rat, or LSEC isolated from rat liver and cultured for 1 or 3 days
were stained with the SE-1, anti-PECAM-1 or RECA antibodies. The far right panel shows
SEM images of LSEC cultured at day 1 and phase contrast images of LSEC cultured at day
1 or 3 are shown. Fluorescence and phase contrast images were acquired with an original
magnification of 20X. (B) Western blotting analyses of total protein from LSEC cultured for
1 or 3 days using the SE-1, anti-PECAM-1 or RECA antibodies. Quantification and
normalization are shown in the right panel.(n=3 +/− SD, p<0.05)
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Figure 2. Identification and characterization of the antigen recognized by the SE-1 antibody
(A) Amino acid sequences of the rat CD32b molecule identified by mass spectrometry. Bold
indicate amino acids predicted by mass spectrometry. (B) LSEC lysate were
immunoprecipitated with the SE-1 antibody and the immunoprecipitated material was
detected by Western blotting either using the mouse anti CD32 or goat anti CD32b
antibodies. (C) HEK cell transfected with rat CD32b cDNA or with the empty vector and
analyzed by western blot using the ab SE-1 (right), HEK cells were transfected with the
CD32b cDNA and stained with the ab SE-1 or an IgG control and analyzed using FACS. (D)
Double immunostaining was performed in liver rat sections using the mAb SE-1 and the
goat anti CD32b polyclonal antibody, followed by fluorescently labeled secondary
antibodies. Original magnification X20. Total protein lysates of human (E) or mouse (F)
LSECs cultured for 4 or 8 days or 1 or 3 days were analyzed by Western blotting using the
antibody CD32b
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Figure 3. Effect of the ECM components on the survival of cultured LSEC
(A) An example of cells patterned atop an ECM microarray at day 1. Left panel shows
staining with the respective antibodies SE-1, anti-PECAM-1 and IgG control following by
incubation with Cy-3-conjugated secondary antibody, the corresponding nuclei are
visualized by Hoechst staining (central panel), and phase contrast images are seen in the
right panel. (B) Representative images of nuclei seen by Hoecht staining with apoptotic
nuclei highlighted with arrows. (C) Average and factorial analysis of the percentage of
apoptotic nuclei at day 2 observed atop varying matrix compositions. (D) Average and
factorial analysis of the total number per cells at day 3 observed atop varying matrix
compositions.
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Figure 4. Role of neighboring cells in maintaining LSEC functional phenotype
(A) Schematic representation of the micromechanical platform used for co-culture
experiments. (B) Phase contrast images of LSEC co-cultured with 3 different combinations
of neighboring cells (C) LSEC co-cultured with 3 differences combinations of neighboring
cells were stained with the monoclonal antibody SE-1, followed by conjugated secondary
antibody. (D) Albumin secretion by hepatocytes alone or in co-culture with LSEC or LSEC/
fibroblast. (E) SE-1(CD32b) quantification of 3 independent experiments between day 6 and
7. (F) Representative experiment of Factor VIII activity in the supernatants of the different
co-cultures.. (G) Uptake of Ac-LDL by the cultured LSEC, a representative experiment of
three individual experiments. (H) LSEC co-cultures with 3 different combinations of
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neighboring cells were performed in two modes (gap or contact) for 7 days. Protein lysates
of LSECs were analyzed by Western blotting using the antibody SE-1 (CD32b). (I) SE-1
(CD32b) expression on LSEC alone or with 3 different combination of neighboring cells
using the transwell system. (J) Inmunostaining and western blot at day 14 using the ab
SE-1(n=3, +/− SD p<0.05)
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